A quantitative reverse transcriptase polymerase chain reaction-based assay to detect carcinoma cells in peripheral blood

British Journal of Cancer

Volumn 76, Issue 1, 1997, Pages 29-35

  Helfrich, W ^a   Ten Poele, R ^a   Meersma, G J ^a   Mulder, N H ^a   De Vries, E G E ^a   De Leij, L ^a   Smit, E F ^a,b  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Blood; Bone marrow; Carcinoma; Metastasis; Quantitative RT PCR

Indexed keywords

MESSENGER RNA; MONOCLONAL ANTIBODY; TUMOR MARKER;

ARTICLE; ASSAY; BLOOD; BONE MARROW; CALIBRATION; CARCINOMA CELL; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; LEUKOCYTE; METASTASIS; NORMAL HUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0031002371     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1997.331     Document Type: Article

References (53)

1. Anderson IC, Shpall EJ, Leslie DS, Nustad K, Ugelstad J, Peters WP and Bast RC Jr (1989) Elimination of mulignant clonogenic breast cancer cells from human bone marrow. Cancer Res 49: 4659-4664
2. Beiske K, Myklebust AT, Aamdal S, Langholm R, Jakobsen E and Fodstad O (1992) Detection of hone marrow metastases in small cell lung cancer patients. Comparison of immunologic and morphologic methods. Am J Pathol 141: 531-538
3. Berendsen HH, de Leij L, de Vries EGE, Mesander G, Mulder NH, de Jong B, Buys CH, Postmus PE, Poppema S, Sluiler HJ and The TH (1988) Characterization of three small cell lung cancer cell lines established from one patient during longitudinal follow-up. Cancer Res 48: 6891-6899
4. Berger U, Bettelheim R, Mansi JL, Easton D, Coombes RC and Neville AM (1988) The relationship between micrometastases in the bone marrow, histopathologic features of the primary tumor in breast cancer and prognosis. Am J Clin Pathol 90: 1-6
5. Brenner MK, Rill DR, Moen RC, Krance RA, Mirro JJr and Anderson WFI (1993) Gene-marking to trace origin of relapse after autologous bone-marrow transplantation. Lancet 341: 85-86
6. Brugger W, Bross KJ, Glatt M, Weber F, Mertelsmann R and Kanz L (1994) Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors. Blood 83: 636-640
7. Bumol TF, Marder P, DeHerdt SV, Borowitz MJ and Apelgren LD (1988) Characterization of the human tumor and normal tissue reactivity of the KS1/4 monoclonal antibody. Hybridoma 7: 407-415
8. Burchill SA, Bradbury MF, Pittman K, Southgate J, Smith B and Selby P (1995) Detection of epithelial cancer cells in peripheral blood by reverse transcriptasepolymerase chain reaction. Br J Cancer 72: 278-281
9. Chelly J, Concordet JP, Kaplan JC and Kahn A (1989) Illegitimate transcription: transcription of any gene in any cell type. Proc Natl Acad Sci USA 86: 2617-2621
10. Chirgwin JM, Przybyla AE, MacDonald RJ and Rutter WJ (1979) Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease, Biochemistry 18: 5294-5299
11. Cote RJ, Rosen PP, Lesser ML, Old LJ and Osborne MP (1991) Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases. J Clin Oncol 9: 1749-1756
12. Datta YH, Adams PT, Drobyski WR, Ethier SP, Terry VH and Roth MS (1994) Sensitive detection of occult breast cancer by the reverse-transcriptase polymeruse chain reaction. J Clin Oncol 12: 475-482
13. Diel IJ, Kaufmann M, Costa SD and Bastert G (1994) Monoclonal antibodies to detect breast cancer cells in hone marrow. In Important Advances in Oncology. Hellman S and Rosenberg SA (eds). JB Lippincott: Philadelphia
14. Elias DJ, Hirschowitz L, Kline LE, Kroener JF, Dillman RO, Walker LE, Robb JA and Timms RM (1990) Phase I clinical comparative study of monoclonal antibody KS1/4 and KS1/4-methotrexate immunconjugate in patients with non-small cell lung carcinoma. Cancer Res 50: 4154-4159
15. Fisher B, Costantino J, Redmond C, Poisson R, Bowman D, Couture J, Dimitrov NV, Wolmark N, Wickerham DL and Fisher ER (1989) A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors. N Engl J Med 320: 479-484
16. Foss AJE, Guille MJ, Occleston NL, Hykin PG, Hungerford JL and Lightman S (1995) The detection of melanoma cells in peripheral blood by reverse transcription-polymerase chain reaction. Br J Cancer 72: 155-159
17. Gerhard M, Juhl H, Kalihoff H, Schreiber HW, Wagener C and Neumaier M (1994) Specific detection of carcinoembryonic antigen-expressing tumor cells in bone marrow aspirates by polymerase chain reaction. J Clin Oncol 12: 725-729
18. Gribben JG, Freedman AS, Neuberg D, Roy DC, Blake KW, Woo SDG, Rabinowe SN, Coral F and Freeman GJ (1991) Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma. N Engl J Med 325: 1525-1533
19. Harbeek N, Untch M, Pache L and Eiermann W (1994) Tumour cell detection in the bone marrow of breast cancer patients at primary therapy: results of a 3-year median follow-up. Br J Cancer 69: 566-571
20. Hardingham JE, Kotasek D, Farmer B, Butler RN, Mi JX and Sage RED (1993) Immunobead-PCR: a technique for the detection of circulating tumor cells using immunomagnetic beads and the polymerase chain reaction. Cancer Res 53: 3455-3458
21. Harlow E and Lane D (1988) Antibodies: A Laboratory Manual. Cold Spring Harbor Laboratory Press: Cold Spring Harbor, NY
22. Herlyn D, Benden A, Kane M, Somasundaram R, Zaloudik J, Sperlagh M, Marks G, Hart E, Ralph C and Wettendorff M (1991) Anti-idiotype cancer vaccines: preclinical and clinical studies. In Vivo 5: 615-623
23. Israeli RS, Miller WH Jr, Su SL, Powell CT, Fair WR, Samadi DSH, DeBlasio A, Edwards ET and Wise GJ (1994) Sensitive nested reverse transcription polymerase chain reaction detection of circulating prostatic tumor cells: comparison of prostate-specific membrane antigen and prostate-specific antigen-based assays. Cancer Res 54: 6306-6310
24. Kok K, Osinga J, Schotanus DC, Berendsen HH, de Leij L and Buys CH (1989) Amplification and expression of different myc-family genes in a tumor specimen and 3 cell lines derived from one small-cell lung cancer patient during longitudinal follow-up. Int J Cancer 44: 75-78
25. 111In-DPTA-MOC-31 in patients with small cell lung carcinoma (SCLC): Pharmacokinetics and scintigraphy. J Nucl Med 36: 2356-2362
26. Krismann M, Todt B, Schroder J, Gareis D, Muller KM, Seeher S and Schutte J (1993) Low specificity of cytokeratin 19 reverse transcriptase-polymerase chain reaction analyses tor detection of hematogenous lung cancer dissemination. J Clin Oncol 13: 2769-2775
27. Kroesen BJ, ter Haar A, Spakman H, Willemse P, Sleijfer DTh, de Vries EGE, Mulder NH, Berendsen HH, Limburg PC. The TH and de Leij L (1993) Local antitumour treatment in carcinoma patients with bispecific-monoclonal-antibody-redirected T cells. Cancer Immunol Immunother 37: 400-407
28. Kroesen BJ, Buter J, Sleijfer DT, Janssen RAJ, Van der Graaf WTA, The TH, de Leij L and Mulder NH (1994) Phase I study of intravenously applied bispecific antibody in renal cell cancer patients receiving subcutaneous interleukin 2. Br J Cancer 70: 652-661
29. de Leij L, Postmus PE, Buys CH, Elema JD, Ramackers F, Poppema S, Brouwer M, van der Veen AY, Mesander G and The TH (1985) Characterization of three new variant type cell lines derived from small cell carcinoma of the lung. Cancer Res 45: 6024-6033
30. de Leij L, Helfrich W, Stein R and Mattes MJ (1994) SCLC-cluster-2 antibodies detect the pancarcinoma/epithelial glycoprotein EGP-2. Int J Cancer 57 (suppl. 8): 60-63
31. Linnenbach AJ, Seng BA, Wu S, Robbins S, Scollon M, Pyre JJ, Druck T and Huehner K (1993) Retroposition in a family of carcinoma-associated antigen genes. Mol Cell Biol 13: 1507-1515
32. Lobuglio AF, Saleh M, Peterson L, Wheeler R, Carrano R, Huster W and Khazaeli MB (1986) Phase I clinical trial of CO17-1A monoclonal antibody. Hybridoma 5 (suppl. 1): S117-S123
33. Matsumura Y and Tarin D (1992) Significance of CD44 gene products for cancer diagnosis and disease evaluation. Lancet 340: 1053-1058
34. Mattano LA Jr, Moss TJ and Emerson SG (1992) Sensitive detection of rare circulating neuroblastoma cells by the reverse transcriptase-polymerase chain reaction. Cancer Res 52: 4701-4705
35. Menard S, Squicciarini P, Luini A, Sacchini V, Rovini D, Tagliahue E, Veronesi P, Salvadori B, Veronesi U and Colnaghi MI (1994) Immunodetection of bone marrow micrometastases in breast carcinoma patients and its correlation with primary tumour prognostic features. Br J Cancer 69: 1126-1129
36. Moertel CG, Fleming TR, Macdonald JS, Haller DG, Laurie JA, Goodman PJ, Ungerleider JS, Emerson WA, Tormey DC and Glick, J-H (1990) Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med 322: 352-358
37. Moss TJ, Cairo M, Santana VM, Weinthal J, Hurvitz C and Bostrom B (1994) Clonogenicity of circulating neuroblastoma cells: implications regarding peripheral blood stem cell transplantation. Blood 83: 3085-3089
38. Myklebust AT, Beiske K, Pharo A, Davies de L, Aamdal S and Fodstad O (1991) Selection of anti-SCLC antibodies for diagnosis of hone marrow metastasis. Br J Cancer 63 (suppl.14): 49-53
39. Myklebust AT, Pharo A and Fodstad O (1993a) Effective removal of SCLC cells from human hone marrow. Use of four monoclonal antibodies and immunomagnetic beads. Br J Cancer 67: 1331-1336
40. Myklebust AT, Godal A, Pharo A, Juell S and Fodstad O (1993b) Eradication of small cell lung cancer cells from human hone marrow with immunotoxins. Cancer Res 53: 3784-3788
41. Norris MD, Gilbert J, Marshall GM and Haber M (1994) Detection of minimal residual neuroblastoma by reverse transcription polymerase chain reaction. Proc Am Assoc Cancer Res 35: 1-218
42. Pantel K, Izbicki JR, Angstwurm M, Braun S, Passlick B, Karg OT and Riethmuller G (1993) Immunocytological detection of bone marrow micrometastasis in operable non-small cell lung cancer. Cancer Res 53: 1027-1031
43. Peter M, Magdelenat H, Michon J, Melot T, Oberlin O, Zucker JM, Thomas G and Delattre O (1995) Sensitive detection of occult Ewing's cells by the reverse transcriptase polymerase chain reaction. Br J Cancer 72: 96-100
44. Sambrook J, Fritsch EF and Maniatis T (1989) Molecular Cloning: A laboratory manual. Cold Spring Harbor Laboratory Press: Cold Spring Harbor, NY
45. Sarkar G and Sommer SS (1989) Access to a messenger RNA sequence or its protein product is not limited by tissue or species specificity. Science 244: 331-334
46. Schlimok G, Funke I, Pantel K, Strobel F, Lindemann F and Witte JR (1991) Micrometastatic tumour cells in bone marrow of patients with gastric cancer: methodological aspects of detection and prognostic significance. Eur J Cancer 27: 1461-1465
47. Seiden MV, Kantoff PW, Krithivas K, Propert K, Bryant M, Haltom EG, Kaplan I, Bubley G and DeWolf W (1994) Detection of circulating tumor cells in men with localized prostate cancer. J Clin Oncol 12: 2634-2639
48. Smith B, Selby P, Southgate J, Pittman K, Bradley C and Blair GE (1991) Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction. Lancet 338: 1227-1229
49. Smith MR, Biggar S and Hussain M (1995) Prostate-specific antigen messenger RNA is expressed in non-prostate cells: implications for detection of micrometastases. Cancer Res 55: 2640-2644
50. Strnad J, Hamilton AE, Beavers LS, Gamboa GC, Apelgren LD, Taber LD, Sportsman JR, Bumol TF, Sharp JD and Gadski RA (1989) Molecular cloning and characterization of a human adenocarcinoma/epithelial cell surface antigen complementary DNA. Cancer Res 49: 314-317
51. Szala S, Froehlich M, Scollon M, Kasai Y, Steplewski Z, Koprowski H and Linnenbach AJ (1990) Molecular cloning of cDNA for the carcinoma-associated antigen GA733-2. Proc Natl Acad Sci USA 87: 3542-3546
52. Withoff S, Smit EF, Meersma GJ, Van den Berg A, Timmer-Bosscha HK, Postmus PE, Mulder NH, de Vries EG and Buys CH (1994) Quantitation of DNA topoisomerase II alpha messenger ribonucleic acid levels in a small cell lung cancer cell line and two drug resistant sublines using a polymerase chain reaction-aided transcript titration assay. Lab Invest 71: 61-66
53. Zijlstra JG, de Vries EG and Mulder NH (1987) Multifactorial drug resistance in an adriamycin-resistant human small cell lung carcinoma cell line. Cancer Res 47: 1780-1784